Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement

K-Number: K260536 · 2026-05-15

Decision Date2026-05-15
Product CodeKWL
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement is a medical device manufactured by Depuy Ireland UC. It received FDA 510(k) clearance on 2026-05-15 under approval number K260536. The device is classified under product code KWL. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement?

Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement is a medical device that received FDA 510(k) clearance on 2026-05-15. It is manufactured by Depuy Ireland UC. The 510(k) number is K260536.

When was Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement approved by the FDA?

Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement received FDA 510(k) clearance on 2026-05-15, under approval number K260536.

What company makes Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement?

Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement is manufactured by Depuy Ireland UC.

What is the FDA product code for Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement?

The FDA product code for Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement is KWL.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.